bis([4-tert-butyl-6-(3-phenylbenzene-6-id-1-yl)-3-pyridinyl]-trimethylsilane);tris(2-(2H-dibenzofuran-2-id-3-yl)-5-phenyl-1,3,4-oxadiazole);tetrakis(iridium);2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;trimethyl-[4-methyl-6-(3-phenylbenzene-6-id-1-yl)-3-pyridinyl]silane;trimethyl-(4-methyl-6-phenyl-3-pyridinyl)silane

C159H140Ir4N12O7Si4-8 — CID 158241269

IUPACbis([4-tert-butyl-6-(3-phenylbenzene-6-id-1-yl)-3-pyridinyl]-trimethylsilane);tris(2-(2H-dibenzofuran-2-id-3-yl)-5-phenyl-1,3,4-oxadiazole);tetrakis(iridium);2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;trimethyl-[4-methyl-6-(3-phenylbenzene-6-id-1-yl)-3-pyridinyl]silane;trimethyl-(4-methyl-6-phenyl-3-pyridinyl)silane
SMILESCC(C)(C)c1cc(-c2[c-]ccc(-c3ccccc3)c2)ncc1[Si](C)(C)C.CC(C)(C)c1cc(-c2[c-]ccc(-c3ccccc3)c2)ncc1[Si](C)(C)C.Cc1cc(-c2[c-]ccc(-c3ccccc3)c2)ncc1[Si](C)(C)C.Cc1cc(-c2[c-]cccc2)ncc1[Si](C)(C)C.Cc1ccc(-c2nnc(-c3[c-]cccc3)o2)cc1.[Ir].[Ir].[Ir].[Ir].[c-]1cc2c(cc1-c1nnc(-c3ccccc3)o1)oc1ccccc12.[c-]1cc2c(cc1-c1nnc(-c3ccccc3)o1)oc1ccccc12.[c-]1cc2c(cc1-c1nnc(-c3ccccc3)o1)oc1ccccc12
InChIInChI=1S/2C24H28NSi.C21H22NSi.3C20H11N2O2.C15H11N2O.C15H18NSi.4Ir/c2*1-24(2,3)21-16-22(25-17-23(21)26(4,5)6)20-14-10-13-19(15-20)18-11-8-7-9-12-18;1-16-13-20(22-15-21(16)23(2,3)4)19-12-8-11-18(14-19)17-9-6-5-7-10-17;3*1-2-6-13(7-3-1)19-21-22-20(24-19)14-10-11-16-15-8-4-5-9-17(15)23-18(16)12-14;1-11-7-9-13(10-8-11)15-17-16-14(18-15)12-5-3-2-4-6-12;1-12-10-14(13-8-6-5-7-9-13)16-11-15(12)17(2,3)4;;;;/h2*7-13,15-17H,1-6H3;5-11,13-15H,1-4H3;3*1-9,11-12H;2-5,7-10H,1H3;5-8,10-11H,1-4H3;;;;/q8*-1;;;;
InChIKeyLTMXOBWXNKOROH-UHFFFAOYSA-N
MW3212.16 g/mol
LogP39.40
Rot. Bonds19

About bis([4-tert-butyl-6-(3-phenylbenzene-6-id-1-yl)-3-pyridinyl]-trimethylsilane);tris(2-(2H-dibenzofuran-2-id-3-yl)-5-phenyl-1,3,4-oxadiazole);tetrakis(iridium);2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;trimethyl-[4-methyl-6-(3-phenylbenzene-6-id-1-yl)-3-pyridinyl]silane;trimethyl-(4-methyl-6-phenyl-3-pyridinyl)silane

bis([4-tert-butyl-6-(3-phenylbenzene-6-id-1-yl)-3-pyridinyl]-trimethylsilane);tris(2-(2H-dibenzofuran-2-id-3-yl)-5-phenyl-1,3,4-oxadiazole);tetrakis(iridium);2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;trimethyl-[4-methyl-6-(3-phenylbenzene-6-id-1-yl)-3-pyridinyl]silane;trimethyl-(4-methyl-6-phenyl-3-pyridinyl)silane (PubChem CID 158241269) has the molecular formula C159H140Ir4N12O7Si4-8 and a molecular weight of 3212.16 g/mol. Its IUPAC name is bis([4-tert-butyl-6-(3-phenylbenzene-6-id-1-yl)-3-pyridinyl]-trimethylsilane);tris(2-(2H-dibenzofuran-2-id-3-yl)-5-phenyl-1,3,4-oxadiazole);tetrakis(iridium);2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;trimethyl-[4-methyl-6-(3-phenylbenzene-6-id-1-yl)-3-pyridinyl]silane;trimethyl-(4-methyl-6-phenyl-3-pyridinyl)silane.

Molecular Properties

Compound Namebis([4-tert-butyl-6-(3-phenylbenzene-6-id-1-yl)-3-pyridinyl]-trimethylsilane);tris(2-(2H-dibenzofuran-2-id-3-yl)-5-phenyl-1,3,4-oxadiazole);tetrakis(iridium);2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;trimethyl-[4-methyl-6-(3-phenylbenzene-6-id-1-yl)-3-pyridinyl]silane;trimethyl-(4-methyl-6-phenyl-3-pyridinyl)silane
PubChem CID158241269
Molecular FormulaC159H140Ir4N12O7Si4-8
Molecular Weight3212.16 g/mol
Exact Mass3212.86
IUPAC Namebis([4-tert-butyl-6-(3-phenylbenzene-6-id-1-yl)-3-pyridinyl]-trimethylsilane);tris(2-(2H-dibenzofuran-2-id-3-yl)-5-phenyl-1,3,4-oxadiazole);tetrakis(iridium);2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;trimethyl-[4-methyl-6-(3-phenylbenzene-6-id-1-yl)-3-pyridinyl]silane;trimethyl-(4-methyl-6-phenyl-3-pyridinyl)silane
SMILESCC(C)(C)c1cc(-c2[c-]ccc(-c3ccccc3)c2)ncc1[Si](C)(C)C.CC(C)(C)c1cc(-c2[c-]ccc(-c3ccccc3)c2)ncc1[Si](C)(C)C.Cc1cc(-c2[c-]ccc(-c3ccccc3)c2)ncc1[Si](C)(C)C.Cc1cc(-c2[c-]cccc2)ncc1[Si](C)(C)C.Cc1ccc(-c2nnc(-c3[c-]cccc3)o2)cc1.[Ir].[Ir].[Ir].[Ir].[c-]1cc2c(cc1-c1nnc(-c3ccccc3)o1)oc1ccccc12.[c-]1cc2c(cc1-c1nnc(-c3ccccc3)o1)oc1ccccc12.[c-]1cc2c(cc1-c1nnc(-c3ccccc3)o1)oc1ccccc12
InChIInChI=1S/2C24H28NSi.C21H22NSi.3C20H11N2O2.C15H11N2O.C15H18NSi.4Ir/c2*1-24(2,3)21-16-22(25-17-23(21)26(4,5)6)20-14-10-13-19(15-20)18-11-8-7-9-12-18;1-16-13-20(22-15-21(16)23(2,3)4)19-12-8-11-18(14-19)17-9-6-5-7-10-17;3*1-2-6-13(7-3-1)19-21-22-20(24-19)14-10-11-16-15-8-4-5-9-17(15)23-18(16)12-14;1-11-7-9-13(10-8-11)15-17-16-14(18-15)12-5-3-2-4-6-12;1-12-10-14(13-8-6-5-7-9-13)16-11-15(12)17(2,3)4;;;;/h2*7-13,15-17H,1-6H3;5-11,13-15H,1-4H3;3*1-9,11-12H;2-5,7-10H,1H3;5-8,10-11H,1-4H3;;;;/q8*-1;;;;
InChIKeyLTMXOBWXNKOROH-UHFFFAOYSA-N
XLogP39.40
TPSA246.66 Ų
H-Bond Donors
H-Bond Acceptors19
Rotatable Bonds19
Heavy Atoms186
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5003212.16
LogP ≤ 539.40
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1019

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze bis([4-tert-butyl-6-(3-phenylbenzene-6-id-1-yl)-3-pyridinyl]-trimethylsilane);tris(2-(2H-dibenzofuran-2-id-3-yl)-5-phenyl-1,3,4-oxadiazole);tetrakis(iridium);2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;trimethyl-[4-methyl-6-(3-phenylbenzene-6-id-1-yl)-3-pyridinyl]silane;trimethyl-(4-methyl-6-phenyl-3-pyridinyl)silane with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of bis([4-tert-butyl-6-(3-phenylbenzene-6-id-1-yl)-3-pyridinyl]-trimethylsilane);tris(2-(2H-dibenzofuran-2-id-3-yl)-5-phenyl-1,3,4-oxadiazole);tetrakis(iridium);2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;trimethyl-[4-methyl-6-(3-phenylbenzene-6-id-1-yl)-3-pyridinyl]silane;trimethyl-(4-methyl-6-phenyl-3-pyridinyl)silane?
The IUPAC name of bis([4-tert-butyl-6-(3-phenylbenzene-6-id-1-yl)-3-pyridinyl]-trimethylsilane);tris(2-(2H-dibenzofuran-2-id-3-yl)-5-phenyl-1,3,4-oxadiazole);tetrakis(iridium);2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;trimethyl-[4-methyl-6-(3-phenylbenzene-6-id-1-yl)-3-pyridinyl]silane;trimethyl-(4-methyl-6-phenyl-3-pyridinyl)silane (CID 158241269) is bis([4-tert-butyl-6-(3-phenylbenzene-6-id-1-yl)-3-pyridinyl]-trimethylsilane);tris(2-(2H-dibenzofuran-2-id-3-yl)-5-phenyl-1,3,4-oxadiazole);tetrakis(iridium);2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;trimethyl-[4-methyl-6-(3-phenylbenzene-6-id-1-yl)-3-pyridinyl]silane;trimethyl-(4-methyl-6-phenyl-3-pyridinyl)silane.
What is the SMILES notation for bis([4-tert-butyl-6-(3-phenylbenzene-6-id-1-yl)-3-pyridinyl]-trimethylsilane);tris(2-(2H-dibenzofuran-2-id-3-yl)-5-phenyl-1,3,4-oxadiazole);tetrakis(iridium);2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;trimethyl-[4-methyl-6-(3-phenylbenzene-6-id-1-yl)-3-pyridinyl]silane;trimethyl-(4-methyl-6-phenyl-3-pyridinyl)silane?
The canonical SMILES for bis([4-tert-butyl-6-(3-phenylbenzene-6-id-1-yl)-3-pyridinyl]-trimethylsilane);tris(2-(2H-dibenzofuran-2-id-3-yl)-5-phenyl-1,3,4-oxadiazole);tetrakis(iridium);2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;trimethyl-[4-methyl-6-(3-phenylbenzene-6-id-1-yl)-3-pyridinyl]silane;trimethyl-(4-methyl-6-phenyl-3-pyridinyl)silane is CC(C)(C)c1cc(-c2[c-]ccc(-c3ccccc3)c2)ncc1[Si](C)(C)C.CC(C)(C)c1cc(-c2[c-]ccc(-c3ccccc3)c2)ncc1[Si](C)(C)C.Cc1cc(-c2[c-]ccc(-c3ccccc3)c2)ncc1[Si](C)(C)C.Cc1cc(-c2[c-]cccc2)ncc1[Si](C)(C)C.Cc1ccc(-c2nnc(-c3[c-]cccc3)o2)cc1.[Ir].[Ir].[Ir].[Ir].[c-]1cc2c(cc1-c1nnc(-c3ccccc3)o1)oc1ccccc12.[c-]1cc2c(cc1-c1nnc(-c3ccccc3)o1)oc1ccccc12.[c-]1cc2c(cc1-c1nnc(-c3ccccc3)o1)oc1ccccc12.
What is the InChIKey of bis([4-tert-butyl-6-(3-phenylbenzene-6-id-1-yl)-3-pyridinyl]-trimethylsilane);tris(2-(2H-dibenzofuran-2-id-3-yl)-5-phenyl-1,3,4-oxadiazole);tetrakis(iridium);2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;trimethyl-[4-methyl-6-(3-phenylbenzene-6-id-1-yl)-3-pyridinyl]silane;trimethyl-(4-methyl-6-phenyl-3-pyridinyl)silane?
The InChIKey is LTMXOBWXNKOROH-UHFFFAOYSA-N. The full InChI is InChI=1S/2C24H28NSi.C21H22NSi.3C20H11N2O2.C15H11N2O.C15H18NSi.4Ir/c2*1-24(2,3)21-16-22(25-17-23(21)26(4,5)6)20-14-10-13-19(15-20)18-11-8-7-9-12-18;1-16-13-20(22-15-21(16)23(2,3)4)19-12-8-11-18(14-19)17-9-6-5-7-10-17;3*1-2-6-13(7-3-1)19-21-22-20(24-19)14-10-11-16-15-8-4-5-9-17(15)23-18(16)12-14;1-11-7-9-13(10-8-11)15-17-16-14(18-15)12-5-3-2-4-6-12;1-12-10-14(13-8-6-5-7-9-13)16-11-15(12)17(2,3)4;;;;/h2*7-13,15-17H,1-6H3;5-11,13-15H,1-4H3;3*1-9,11-12H;2-5,7-10H,1H3;5-8,10-11H,1-4H3;;;;/q8*-1;;;;.
What are the key properties of bis([4-tert-butyl-6-(3-phenylbenzene-6-id-1-yl)-3-pyridinyl]-trimethylsilane);tris(2-(2H-dibenzofuran-2-id-3-yl)-5-phenyl-1,3,4-oxadiazole);tetrakis(iridium);2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;trimethyl-[4-methyl-6-(3-phenylbenzene-6-id-1-yl)-3-pyridinyl]silane;trimethyl-(4-methyl-6-phenyl-3-pyridinyl)silane?
bis([4-tert-butyl-6-(3-phenylbenzene-6-id-1-yl)-3-pyridinyl]-trimethylsilane);tris(2-(2H-dibenzofuran-2-id-3-yl)-5-phenyl-1,3,4-oxadiazole);tetrakis(iridium);2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;trimethyl-[4-methyl-6-(3-phenylbenzene-6-id-1-yl)-3-pyridinyl]silane;trimethyl-(4-methyl-6-phenyl-3-pyridinyl)silane has a molecular weight of 3212.16 g/mol, XLogP of 39.40, 19 rotatable bonds, 0 hydrogen bond donors, and 19 hydrogen bond acceptors.
Where does this data come from?
All data for bis([4-tert-butyl-6-(3-phenylbenzene-6-id-1-yl)-3-pyridinyl]-trimethylsilane);tris(2-(2H-dibenzofuran-2-id-3-yl)-5-phenyl-1,3,4-oxadiazole);tetrakis(iridium);2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;trimethyl-[4-methyl-6-(3-phenylbenzene-6-id-1-yl)-3-pyridinyl]silane;trimethyl-(4-methyl-6-phenyl-3-pyridinyl)silane is sourced from PubChem (CID 158241269), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).